Frankel SR[au] - Search Results

Year	Number of Results
1980	1
1984	1
1985	1
1990	1
1991	3
1992	6
1993	5
1994	4
1995	2
1996	1
1997	1
1998	2
1999	3
2000	3
2001	1
2002	5
2003	6
2004	3
2005	4
2006	3
2007	5
2008	5
2009	1
2012	1
2013	2
2014	1
2015	1
2024	0

1

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al. Larson RA, et al. Among authors: frankel sr. Blood. 1995 Apr 15;85(8):2025-37. Blood. 1995. PMID: 7718875 Free article. Clinical Trial.

2

Targeting T cells to tumor cells using bispecific antibodies.

Frankel SR, Baeuerle PA. Frankel SR, et al. Curr Opin Chem Biol. 2013 Jun;17(3):385-92. doi: 10.1016/j.cbpa.2013.03.029. Epub 2013 Apr 25. Curr Opin Chem Biol. 2013. PMID: 23623807 Review.

3

Acute promyelocytic leukemia. New insights into diagnosis and therapy.

Frankel SR. Frankel SR. Hematol Oncol Clin North Am. 1993 Feb;7(1):109-38. Hematol Oncol Clin North Am. 1993. PMID: 8449855 Review.

4

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment.

Klasa RJ, Gillum AM, Klem RE, Frankel SR. Klasa RJ, et al. Among authors: frankel sr. Antisense Nucleic Acid Drug Dev. 2002 Jun;12(3):193-213. doi: 10.1089/108729002760220798. Antisense Nucleic Acid Drug Dev. 2002. PMID: 12162702 Review.

5

Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: case report and review of literature.

Truica CI, Frankel SR. Truica CI, et al. Among authors: frankel sr. Am J Hematol. 2002 Aug;70(4):320-3. doi: 10.1002/ajh.10152. Am J Hematol. 2002. PMID: 12210815 Free article. Review.

6

Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer.

Herbst RS, Frankel SR. Herbst RS, et al. Among authors: frankel sr. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4245s-4248s. doi: 10.1158/1078-0432.CCR-040018. Clin Cancer Res. 2004. PMID: 15217967 Review.

7

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, Pestronk A, Rajkumar V, Treon SP. Gertz MA, et al. Among authors: frankel sr. Semin Oncol. 2003 Apr;30(2):121-6. doi: 10.1053/sonc.2003.50039. Semin Oncol. 2003. PMID: 12720120 Review.

8

Oblimersen sodium (G3139 Bcl-2 antisense oligonucleotide) therapy in Waldenstrom's macroglobulinemia: a targeted approach to enhance apoptosis.

Frankel SR. Frankel SR. Semin Oncol. 2003 Apr;30(2):300-4. doi: 10.1053/sonc.2003.50041. Semin Oncol. 2003. PMID: 12720157 Review.

9

Extended rituximab therapy in Waldenström's macroglobulinemia.

Treon SP, Emmanouilides C, Kimby E, Kelliher A, Preffer F, Branagan AR, Anderson KC, Frankel SR; Waldenström's Macroglobulinemia Clinical Trials Group. Treon SP, et al. Among authors: frankel sr. Ann Oncol. 2005 Jan;16(1):132-8. doi: 10.1093/annonc/mdi022. Ann Oncol. 2005. PMID: 15598950 Free article. Clinical Trial.

10

The power and perils of prediction.

Frankel SR. Frankel SR. Cancer J. 2003 Jan-Feb;9(1):28-30. doi: 10.1097/00130404-200301000-00005. Cancer J. 2003. PMID: 12602764 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year